<DOC>
	<DOC>NCT00432198</DOC>
	<brief_summary>To investigate the efficacy and safety of zolpidem for pediatric insomniacs in a randomized double blind-controlled trial</brief_summary>
	<brief_title>Zolpidem Postmarketing Study in Adolescent Patients With Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>patients diagnosed as having nonorganic insomnia of nonorganic sleep disorder in ICD10 patients whose age at the time of obtaining consent is 12 years or over and 18 years or below patients with schizophrenia or manicdepressive illness patients with insomnia caused by physical diseases patients having a history of hypersensitivity to zolpidem patients with attentiondeficit hyperactivity disorder</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Zolpidem</keyword>
	<keyword>Adolescent</keyword>
</DOC>